Gi partners announces agreement to sell generate life sciences to coopercompanies

San francisco, nov. 10, 2021 /prnewswire/ -- gi partners, a leading private investment firm, today announced the signing of a definitive agreement to sell generate life sciences ("generate"), a leading life sciences platform that provides reproductive and newborn stem cell (umbilical cord blood and tissue) services, to coopercompanies (nyse:coo). generate life sciences was created by gi partners in 2018 as the combination of california cryobank life sciences, an industry-leading donor sperm and egg bank, and cord blood registry, a leading provider of newborn stem cell services.
COO Ratings Summary
COO Quant Ranking